Literature DB >> 30464112

Low Cholesterol Levels Increase Symptomatic Intracranial Hemorrhage Rates After Intravenous Thrombolysis: A Multicenter Cohort Validation Study.

Sheng-Feng Lin1,2, A-Ching Chao3,4, Han-Hwa Hu5,6,7, Ruey-Tay Lin3,4, Chih-Hung Chen8,9, Lung Chan7, Huey-Juan Lin10, Yu Sun11, Yung-Yang Lin12, Po-Lin Chen13, Shinn-Kuang Lin14, Cheng-Yu Wei15, Yu-Te Lin16, Jiunn-Tay Lee17, Chyi-Huey Bai1,18.   

Abstract

AIM: Although a lower level of non-high-density lipoprotein cholesterol (HDL-C) was reported to be inversely associated with spontaneous intracranial hemorrhage (ICH), no enough evidence has verified whether lipid profiles modify hemorrhagic transformation and functional outcomes in patients with acute ischemic treated with thrombolysis.
METHODS: This multicenter cohort study included 2373 patients with acute ischemic stroke treated with intravenous thrombolysis between December 2004 and December 2016. Of these, 1845 patients were categorized into either the hyperlipidemia or non-hyperlipidemia group. Symptomatic ICH (SICH) rates within 24-36 h of thrombolytic onset and functional outcomes at 30 and 90 days were longitudinally surveyed. Models of predicting hemorrhagic transformation were used to validate our findings.
RESULTS: For enrolled 1845 patients, SICH rates were ≥2-fold reduced for the hyperlipidemia group by the NINDS (adjusted RR: 0.488 [0.281-0.846], p=0.0106), the ECASS II (adjusted RR: 0.318 [0.130-0.776], p=0.0119), and SITS-MOST standards (adjusted RR: 0.214 [0.048-0.957], p=0.0437). The favorable functional rates between the two groups were not significantly different. Lower levels of LDL-C were showed in robust association with SICH. With a cut-off LDL-C value of <130 mg/dL, new models are more robust and significant in predicting hemorrhagic transformation within 24-36 h.
CONCLUSIONS: This study supports the strong association between reduced LDL-C and increased SICH, but not for functional outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis. LDL-C level of <130 mg/dL is supposed to a candidate marker for predicting SICH within 24-36 h.

Entities:  

Keywords:  Cholesterol; Intracranial hemorrhage; Low-density lipoprotein cholesterol (LDL-C); Stroke; Thrombolysis

Mesh:

Substances:

Year:  2018        PMID: 30464112      PMCID: PMC6545455          DOI: 10.5551/jat.46151

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  38 in total

1.  Estimating the relative risk in cohort studies and clinical trials of common outcomes.

Authors:  Louise-Anne McNutt; Chuntao Wu; Xiaonan Xue; Jean Paul Hafner
Journal:  Am J Epidemiol       Date:  2003-05-15       Impact factor: 4.897

2.  Low LDL cholesterol, statins, and brain hemorrhage: should we worry?

Authors:  Larry B Goldstein
Journal:  Neurology       Date:  2007-03-06       Impact factor: 9.910

3.  Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

Authors:  Nils Wahlgren; Niaz Ahmed; Antoni Dávalos; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Sonja Kuelkens; Vincent Larrue; Kennedy R Lees; Risto O Roine; Lauri Soinne; Danilo Toni; Geert Vanhooren
Journal:  Lancet       Date:  2007-01-27       Impact factor: 79.321

4.  Low LDL cholesterol, statins, and brain hemorrhage: should we worry?

Authors:  Luca Mascitelli; Francesca Pezzetta
Journal:  Neurology       Date:  2007-09-04       Impact factor: 9.910

5.  Risk factors for primary intracerebral hemorrhage: a population-based nested case-control study.

Authors:  Elisabet Zia; Hélène Pessah-Rasmussen; Farhad Ali Khan; Bo Norrving; Lars Janzon; Goran Berglund; Gunnar Engstrom
Journal:  Cerebrovasc Dis       Date:  2005-11-08       Impact factor: 2.762

6.  Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis.

Authors:  O Y Bang; J L Saver; D S Liebeskind; S Starkman; P Villablanca; N Salamon; B Buck; L Ali; L Restrepo; F Vinuela; G Duckwiler; R Jahan; T Razinia; B Ovbiagele
Journal:  Neurology       Date:  2006-12-20       Impact factor: 9.910

7.  Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe.

Authors:  M L Bots; P C Elwood; Y Nikitin; J T Salonen; A Freire de Concalves; D Inzitari; J Sivenius; V Benetou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

8.  Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups.

Authors:  D L Tirschwell; N L Smith; S R Heckbert; R N Lemaitre; W T Longstreth; B M Psaty
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

9.  Risk factors for intracerebral hemorrhage in a pooled prospective study.

Authors:  Jared D Sturgeon; Aaron R Folsom; W T Longstreth; Eyal Shahar; Wayne D Rosamond; Mary Cushman
Journal:  Stroke       Date:  2007-08-30       Impact factor: 7.914

10.  Influence of hypertension, lipometabolism disorders, obesity and other lifestyles on spontaneous intracerebral hemorrhage.

Authors:  Jun-Fu Zhou; Ji-Yue Wang; Yan-Er Luo; Huai-Hong Chen
Journal:  Biomed Environ Sci       Date:  2003-09       Impact factor: 3.118

View more
  5 in total

1.  Association between non-high-density lipoprotein cholesterol and haemorrhagic transformation in patients with acute ischaemic stroke.

Authors:  Yanan Wang; Quhong Song; Yajun Cheng; Chenchen Wei; Chen Ye; Junfeng Liu; Bo Wu; Ming Liu
Journal:  BMC Neurol       Date:  2020-02-07       Impact factor: 2.474

2.  The association between monocyte to high-density lipoprotein ratio and hemorrhagic transformation in patients with acute ischemic stroke.

Authors:  Yanan Wang; Yajun Cheng; Quhong Song; Chenchen Wei; Junfeng Liu; Bo Wu; Ming Liu
Journal:  Aging (Albany NY)       Date:  2020-02-05       Impact factor: 5.682

3.  Association between low-density cholesterol change and outcomes in acute ischemic stroke patients who underwent reperfusion therapy.

Authors:  Ting Cui; Changyi Wang; Qiange Zhu; Anmo Wang; Xuening Zhang; Shucheng Li; Yuan Yang; Wenzuo Shang; Rong Peng; Bo Wu
Journal:  BMC Neurol       Date:  2021-09-16       Impact factor: 2.474

4.  Triglyceride-Glucose Index and Intravenous Thrombolysis Outcomes for Acute Ischemic Stroke: A Multicenter Prospective-Cohort Study.

Authors:  Sheng-Feng Lin; Han-Hwa Hu; Hai-Lun Chao; Bo-Lin Ho; Chih-Hung Chen; Lung Chan; Huey-Juan Lin; Yu Sun; Yung-Yang Lin; Po-Lin Chen; Shinn-Kuang Lin; Cheng-Yu Wei; Yu-Te Lin; Jiunn-Tay Lee; A-Ching Chao
Journal:  Front Neurol       Date:  2022-02-14       Impact factor: 4.003

5.  Differential influences of LDL cholesterol on functional outcomes after intravenous thrombolysis according to prestroke statin use.

Authors:  You-Ri Kang; Joon-Tae Kim; Ji Sung Lee; Beom Joon Kim; Kyusik Kang; Soo Joo Lee; Jae Guk Kim; Jae-Kwan Cha; Dae-Hyun Kim; Tai Hwan Park; Kyung Bok Lee; Jun Lee; Keun-Sik Hong; Yong-Jin Cho; Hong-Kyun Park; Byung-Chul Lee; Kyung-Ho Yu; Mi Sun Oh; Dong-Eog Kim; Wi-Sun Ryu; Jay Chol Choi; Jee-Hyun Kwon; Wook-Joo Kim; Dong-Ick Shin; Sung Il Sohn; Jeong-Ho Hong; Man-Seok Park; Kang-Ho Choi; Ki-Hyun Cho; Jong-Moo Park; Sang-Hwa Lee; Juneyoung Lee; Hee-Joon Bae
Journal:  Sci Rep       Date:  2022-09-14       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.